According to the attorney general’s office, beginning in 2012, Lisa Kwapniowski began falsifying invoices for a fake drug called Broxcilam to a company called RxSYnergy, which she created.
2016 and 2017 were Ms. Kwapniowski’s most profitable years, as she submitted $1.1 million in false claims during both. Hospital administrators learned of the embezzlement this year and terminated Ms. Kwapniowski while turning the matter over to authorities, WOWT News reported.
More articles on healthcare finance:
Vanderbilt University Medical Center’s finances bounce back after EMR launch
Tower Health attributes operating loss to Epic install, acquisition costs
Kaiser’s net income dips 23% in first 9 months of 2018